SNT
SYNTARA FPO [SNT]
Healthcare · ASX Small Cap
$0.0320 +3.2%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +6First seen: 2026-02-25
Score Breakdown
Technical50
Catalyst53
Sentiment50
Fundamental65
Momentum31
Risk Gate45
Active Signals
Bullish Signals
- Stochastic bullish crossover (from low)
- Volatility contracting (breakout setup)
- Adequate cash runway (5 quarters)
- Moderate P/S ratio (6.9x)
- Revenue in sharp decline (-55%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (12% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (15%)
- Low-priced stock risk ($0.031)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE3 (est. 2010-04)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (3/9)
- Deeply negative margins (-109%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-43%)
- Revenue momentum declining (-55%)
Recent Catalysts
NONE Application for quotation of securities - SNT
NONE Half Year Report and Appendix 4D
NONE Application for quotation of securities - SNT
LOW Investor Presentation Euroz Hartleys Healthcare Forum
Announcement tone +3pts
Recent ASX Announcements
| 2026-02-27 | Application for quotation of securities - SNT |
| 2026-02-25 | Half Year Report and Appendix 4D PRICE SENSITIVE |
| 2026-02-23 | Application for quotation of securities - SNT |
| 2026-02-17 | Notification regarding unquoted securities - SNT |
| 2026-02-04 | Investor Presentation Euroz Hartleys Healthcare Forum |
Key Metrics
$50.6M
Market Cap
1.1M
Avg Volume
0.7x
Vol Ratio
$0.02 — $0.09
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-118.4%
ROE
-108.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 76% |
| L | Leader vs Laggard | laggard | RS: 1 |
| I | Institutional Sponsorship | pass | Inst: 16% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #45 of 119 · Sector avg: 51
View all Healthcare signals →